Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2021 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
CNTX on Nasdaq
Shares outstanding
92,935,152
Price per share
$1.04
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
68,966,266
Total reported value
$66,815,968
% of total 13F portfolios
0%
Share change
+361,686
Value change
+$689,909
Number of holders
37
Price from insider filings
$1.04
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MPM BioImpact LLC 16% $14,705,882 14,705,882 MPM BioImpact LLC 31 Dec 2024
Avidity Partners Management LP 9.9% 0% $8,913,522 +$72,083 9,200,580 +0.82% Avidity Partners Management LP 30 Sep 2025
Deep Track Capital, LP 8.3% $7,419,355 7,419,355 Deep Track Capital, LP 31 Mar 2025
Blue Owl Capital Holdings LP 8.5% $6,357,928 6,357,928 Blue Owl Capital Holdings LP 31 Dec 2024
GREAT POINT PARTNERS LLC 5.2% 0% $4,537,579 4,683,711 0% Great Point Partners, LLC 30 Sep 2025
FRANKLIN RESOURCES INC 4.5% -16% $4,003,380 4,003,380 0% Franklin Resources, Inc. 31 Mar 2025
Lehr Martin A. 2.1% $1,595,742 1,595,742 Martin Lehr 31 Dec 2024

As of 30 Sep 2025, 37 institutional investors reported holding 68,966,266 shares of Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX). This represents 74% of the company’s total 92,935,152 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) together control 74% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
MPM BIOIMPACT LLC 16% 14,705,882 0% 2.3% $14,247,058
Avidity Partners Management LP 9.7% 8,981,855 +20% 2% $8,701,621
Nextech Invest, Ltd. 8% 7,419,355 0% 1.1% $7,187,871
Deep Track Capital, LP 8% 7,419,355 0% 0.2% $7,187,871
Blue Owl Capital Holdings LP 8% 7,407,906 0% 2.2% $7,176,779
GREAT POINT PARTNERS LLC 5% 4,683,711 0% 1.9% $4,537,579
FRANKLIN RESOURCES INC 4.3% 4,003,380 0% 0% $3,878,475
VANGUARD GROUP INC 3.8% 3,495,031 +4% 0% $3,386,685
Blackstone Inc. 2.6% 2,440,330 0% 0.01% $2,364,680
Alyeska Investment Group, L.P. 1.8% 1,663,355 0% 0% $1,611,458
Nantahala Capital Management, LLC 1.8% 1,661,950 -14% 0.1% $1,610,097
Sio Capital Management, LLC 1.4% 1,341,636 0% 0.33% $1,299,777
BlackRock, Inc. 0.91% 848,970 0% 0% $822,482
GEODE CAPITAL MANAGEMENT, LLC 0.65% 608,577 -4.6% 0% $589,897
Affinity Asset Advisors, LLC 0.43% 402,653 -22% 0.04% $390,090
ADAR1 Capital Management, LLC 0.38% 351,094 0% 0.03% $340,140
RENAISSANCE TECHNOLOGIES LLC 0.34% 320,127 -12% 0% $310,139
STATE STREET CORP 0.16% 152,607 0% 0% $147,846
Walleye Capital LLC 0.14% 132,786 0% 0% $128,643
HighTower Advisors, LLC 0.14% 125,852 0% 0% $121,925
Pathstone Holdings, LLC 0.12% 110,244 0% $106,804
Mill Creek Capital Advisors, LLC 0.11% 104,631 0% 0% $101,367
CITADEL ADVISORS LLC 0.11% 103,363 0% $100,138
Velan Capital Investment Management LP 0.11% 100,000 0% 0.09% $96,880
Clear Harbor Asset Management, LLC 0.1% 92,804 +61% 0.01% $89,909

Institutional Holders of Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 68,966,266 $66,815,968 +$689,909 $0.97 37
2025 Q2 68,619,580 $44,959,003 -$1,721,044 $0.66 39
2025 Q1 71,405,968 $43,712,940 -$1,099,517 $0.61 42
2024 Q4 72,797,034 $76,436,064 +$15,827,475 $1.05 52
2024 Q3 56,682,696 $111,154,599 -$854,175 $1.96 42
2024 Q2 57,034,586 $114,325,460 +$107,182,399 $2.00 34
2024 Q1 3,935,132 $5,430,813 +$524,452 $1.38 25
2023 Q4 3,558,639 $4,020,714 +$1,102,318 $1.13 24
2023 Q3 2,578,656 $3,893,359 +$507,040 $1.51 23
2023 Q2 2,239,166 $3,582,021 +$1,631,639 $1.60 22
2023 Q1 1,276,355 $717,889 -$1,585,759 $0.56 20
2022 Q4 3,883,345 $2,545,096 -$383,818 $0.65 23
2022 Q3 4,130,839 $4,587,000 +$1,461,710 $1.11 21
2022 Q2 2,747,803 $5,761,000 -$388,653 $2.12 17
2022 Q1 2,904,420 $6,302,000 -$2,229,327 $2.17 12
2021 Q4 3,549,370 $9,441,000 +$8,486,000 $2.66 16